NCT02061384View on ClinicalTrials.gov

RA-2 13-cis Retinoic Acid (Isotretinoin)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Male InfertilityKlinefelter's SyndromeY-chromosome Microdeletions
Interventions
DRUG

13-cis retinoic acid

Accutane is used for the treatment of severe acne

DRUG

Calcitriol

Calcitriol is a form of vitamin D given twice daily (BID)

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT02061384 - RA-2 13-cis Retinoic Acid (Isotretinoin) | Biotech Hunter | Biotech Hunter